This site is intended for health professionals only

Home / News / LloydsPharmacy owner looks to exit UK

LloydsPharmacy owner looks to exit UK

Lloyds Pharmacy

By Beth Gault

07 Jul 2021

The parent of LloydsPharmacy, McKesson, has sold a number of its European businesses, with the view to ‘fully exit’ the European region.

McKesson Corporation today (7 July) entered an agreement to sell a number of its European businesses, including in France, Italy, Ireland, Portugal, Belgium and Slovenia to integrated healthcare provider Phoenix Group.

It will continue to operate its business in the UK but said it is ‘exploring’ a path to exit Europe altogether.

McKesson’s chief executive, Brian Tyler, said: ‘We will continue to operate our remaining businesses in the UK, Norway, Austria, and Denmark while also exploring a strategic path forward to fully exit the European region. Our goal is to accelerate our growth strategies, becoming a more focused organization and enabling our mission to improve care in every setting.’

He added: ‘Today’s transaction marks an important step in advancing McKesson’s commitment to streamline the business and prioritize investments in the areas where we have deep expertise and are central to our long-term growth strategy.’

It comes after LloydsPharmacy’s online arm Echo was renamed LloydsDirect.


Want news like this straight to your inbox?


Latest News

Plan B
Government must consider ‘sensible measures’ to protect pharmacy teams this winter, RPS says
The Royal Pharmaceutical Society (RPS) is calling on the Government to implement ‘sensible measures’ to...
antiviral drugs
Covid antiviral drugs could be prescribed to prevent hospital admission ‘this winter’
The Government has made deals for hundreds of thousands of doses of two new antiviral...
Chronic fatigue
NICE to publish chronic fatigue guideline after final meeting next week
NICE will publish its long-anticipated updated guideline for myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS)...